Siren »

Centessa Pharmaceuticals shares owned by Siren

Quarter-by-quarter ownership of Centessa Pharmaceuticals (CNTA) shares owned by Siren from 13F filings

Historical chart of Siren investment in Centessa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Centessa Pharmaceuticals held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Centessa Pharmaceuticals by Siren

Quarter filed Position value Share count Share price at filing
2024-09-30 $52M 3.3M 15.99

More positions owned by Siren

Kymera Therapeutics (KYMR)
Beigene Sponsored Adr
Scholar Rock Hldg Corp (SRRK)
Bicara Therapeutics (BCAX)
Argenx SE Sponsored Adr (ARGX)
Crinetics Pharmaceuticals In (CRNX)
Avidity Biosciences Ord (RNA)
Apellis Pharmaceuticals (APLS)
Lexicon Pharmaceuticals Com New (LXRX)
Igm Biosciences (IGMS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Ascendis Pharma A/S Sponsored Adr (ASND)
Silence Therapeutics Ads (SLN)
Arrowhead Pharmaceuticals (ARWR)
WAVE Life Sciences SHS (WVE)

View all positions for Siren

Top funds holding Centessa Pharmaceuticals

Medicxi Ventures Management
General Atlantic
Perceptive Advisors
First Light Asset Management
T. Rowe Price Associates
Adage Capital Partners GP
Henderson Group
Vida Ventures Advisors
FMR
T. Rowe Price Investment Management
Farallon Capital Management
Point72 Asset Management
Siren
TCG Crossover Management
Cormorant Asset Management

View all funds holding Centessa Pharmaceuticals